Kliničke studije za KOPB u državi Alabama
21 studija za KOPB traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 2
Od 40 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
U tijeku regrutacijaFaza 4
Od 40 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
U tijeku regrutacijaFaza 2/3
Od 35 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 11. kol 2026. · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
U tijeku regrutacijaOpažajna studija
Od 50 do 99 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 31. srp 2026. · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 22 godina i više · Oba spola · Ažurirano 23. lip 2026. · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 30 do 55 godina · Oba spola · Ažurirano 3. lip 2026. · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
U tijeku regrutacija
Od 40 do 80 godina · Oba spola · Ažurirano 28. tra 2026. · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 40 do 84 godina · Oba spola · Ažurirano 24. tra 2026. · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 16. sij 2026. · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 4
Od 19 godina i više · Oba spola · Ažurirano 10. stu 2025. · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
U tijeku regrutacija
Od 30 godina i više · Oba spola · Ažurirano 6. velj 2025. · NCT05204888Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.